Document text
FINAL - October 23, 2023
8:00 Welcome & Introductions Dr. Grace Lee (ACIP Chair)
Dr. Melinda Wharton (ACIP Executive Secretary, CDC)
8:30 Meningococcal Vaccines
Introduction
Plan for revisiting adolescent schedule for meningococcal vaccinesComparison of Pfizer and CDC cost effectiveness analysesSummary of EtR and proposed recommendations for Pfizer’s
MenABCWY vaccine
Vaccines for Children ResolutionDr. Kathy Poehling (ACIP, WG Chair)
Dr. Lucy McNamara (CDC/NCIRD)Dr. Ismael Ortega-Sanchez (CDC/NCIRD)Dr. Jennifer Collins (CDC/NCIRD)
Dr. Jeanne Santoli (CDC/NCIRD)
10:10 Break
10:25 Mpox Vaccines
Introduction
Updates about U.S. mpox epidemiology, vaccine safety, and vaccine
effectiveness
Evidence to recommendations framework
Review of voting language and clinical guidanceVaccines for Children resolutionDr. Pablo Sanchez (ACIP, WG Chair)Dr. Faisal Minhaj (CDC/NCEZID)
Dr. Agam Rao (CDC/NCEZID)
Dr. Agam Rao (CDC/NCEZID)Dr. Jeanne Santoli (CDC/NCIRD)
12:15 Break
12:45 Public Comment
1:00 VOTES
Meningococcal Vote
Meningococcal VFC VoteMpox VoteMpox VFC VoteDr. Jennifer Collins (CDC/NCIRD)Dr. Jeanne Santoli (CDC/NCIRD)Dr. Agam Rao (CDC/NCEZID)Dr. Jeanne Santoli (CDC/NCIRD)
1:30 Break
1:45 RSV - Adults
Introduction
GSK safety and immunogenicity in persons 50-59 years of ageEpidemiology of RSV in adultsWork group interpretation and ACIP discussionDr. Camille Kotton (ACIP, WG Chair)Dr. Susan Gerber (GSK)Dr. Monica Patton (CDC/NCIRD)Dr. Amadea Britton (CDC/NCIRD)
3:00 Influenza Vaccines
Introduction
Safety of quadrivalent recombinant influenza vaccine in pregnant
women and their infants
Pregnancy outcomes with ccIIV4 (Flucelvax): results of a post-
marketing study
Safety of simultaneous versus sequential administration of mRNA
COVID-19 and Quadrivalent Inactivated Influenza (IIV4) Vaccines:
A randomized placebo controlled trial
Safety of simultaneous vaccination with Zoster Vaccine Recombinant
(RZV) and quadrivalent Adjuvanted Inactivated Influenza Vaccine
(allV4)Dr. Jamie Loehr (ACIP, WG Chair)
Dr. Nicky Klein (Kaiser Permanente Northern California)
Dr. Gregg Sylvester (Seqirus)
Dr. Chip Walter (Duke University)
Dr. Ken Schmader (Duke University)
4:30 Vaccine Safety Update
Update on COVID-19 and Influenza Vaccine Safety Dr. Tom Shimabukuro (CDC/NCEZID)
5:30 AdjournMEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Centers for Disease Control and Prevention
Atlanta, Georgia 30329
October 25-26, 2023
Wednesday, October 25, 2023
FINAL - October 23, 2023
8:00 Welcome & Introductions Dr. Grace Lee (ACIP Chair)
Dr. Melinda Wharton (ACIP Executive Secretary, CDC)
8:10 Agency Updates
8:30 Combined Immunization Schedules
Introduction to 2024 adult and child/adolescent immunization
schedule
2024 child and adolescent schedule revisions
2024 adult schedule revisions Dr. Sybil Cineas (ACIP, WG Chair)
Dr. Patricia Wodi (CDC/NCIRD)
Dr. Neil Murthy (CDC/NCIRD)
9:50 Break
10:00 Public Comment
10:15 VOTES
Immunization Schedules Vote Dr. Patricia Wodi (CDC/NCIRD), Dr. Neil Murthy
(CDC/NCIRD)
10:30 Chikungunya Vaccine
Introduction
EtR and proposed policy options for chikungunya vaccine use among
U.S. adults traveling abroad
EtR and proposed policy options for chikungunya vaccine use among
laboratory workersDr. Beth Bell (ACIP, WG Chair)
Dr. Susan Hills (CDC/NCEZID)
Dr. Susan Hills (CDC/NCEZID)
11:40 Dengue Vaccines
Takeda dengue vaccine update Dr. Wilbur Chen (ACIP, WG Chair)
11:45 Break
12:00 COVID-19 Vaccines
Introduction
COVID-19 vaccine implementationCOVID-19 vaccine policy and next steps Dr. Matt Daley (ACIP, WG Chair)Dr. Shannon Stokley (CDC/NCIRD)Dr. Megan Wallace (CDC/NCIRD)
12:50 Pneumococcal Vaccines
Work Group Updates and Next Steps Dr. Miwako Kobayashi (CDC/NCIRD)
1:00 Influenza Vaccines
Effectiveness of maternal influenza vaccination during pregnancy
against influenza-associated hospitalizations & emergency departmevisits in infants <6 Months of Age
Update on influenza B/Yamagata surveillancen
t Ms. Samantha Olson (CDC/NCIRD)
Dr. Rebecca Kondor (CDC/NCIRD)
1:40 Adjourn
Acronyms
CDC
CMS Centers for Medicare and Medicaid Services
COVID-19 Coronavirus disease 2019
EtR Evidence to Recommendations Framework
FDA Food and Drug Administration
GRADE
HRSA Health Resources and Services Administration
IHS Indian Health Service
LAIV4 Live Attenuated Influenza Vaccine
NCHHSTP
NCIRD
NCEZID
NIAID
OIDP Office of Infectious Disease and HIV/AIDS Policy
SARS-CoV-2 Severe Acute Respiratory Syndrome Coronavirus 2
WG Work Group
WHO World Health Organization
VE Vaccine EffectivenessNational Institute of Allergy and Infectious DiseasesCenters for Disease Control and Prevention
Grading of Recommendations Assessment, Development and Evaluation
National Center for HIV, Hepatitis, STD and TB Prevention [of CDC/OID]
National Center for Immunization & Respiratory Diseases [of CDC/OID]
National Center for Emerging and Zoonotic Diseases [of CDC/OID]Thursday, October 26, 2023